))
The Neuropreneur Molecules to Market
Manage episode 499058359 series 3591921
Content provided by Michael Mannino Sr. & Nareman Hamdan, Michael Mannino Sr., and Nareman Hamdan. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Michael Mannino Sr. & Nareman Hamdan, Michael Mannino Sr., and Nareman Hamdan or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this inspiring episode of Driven: Unscripted Success, Nareman Hamdan welcomes Dr. Steve Paul—psychiatrist, neurologist, and biotech entrepreneur. Dr. Paul is the founder and chairman of Seaport Therapeutics, a venture partner at Third Rock Ventures, and has helped develop breakthrough medications that treat depression, ADHD, schizophrenia, and postpartum depression.
From his early career at the NIH under Nobel Laureate Julius Axelrod to leading R&D at Eli Lilly, Dr. Paul shares his journey across government, big pharma, and biotech. Hear about the risks he took in founding multiple companies, including the emotional resonance of creating the first FDA-approved treatment for postpartum depression—an achievement made even more personal when his own daughter battled the condition.
This episode covers:
The science behind mental health medication
How Prozac changed public perception of depression
Starting biotech companies from scratch
Building teams of “group genius” in science and business
His recent work with AI and brain signals
Balancing risk, wealth, family, and a lifelong love of learning
---------------------------------------------------------- Be a Guest: Are you a successful Naples-area business owner, entrepreneur, or professional with insights to share? Apply to be a guest at Driven: Unscripted Success and share your expertise with a wide audience eager to learn about you.
95 episodes
Share
